发明授权
- 专利标题： Enantiomerically pure phosphoindoles as HIV inhibitors
- 专利标题（中）： 对映异构纯的磷酸吲哚作为HIV抑制剂
-
申请号： US11906095申请日： 2007-09-28
-
公开(公告)号： US07960428B2公开(公告)日： 2011-06-14
- 发明人: Richard Storer , Francois-Rene Alexandre , Cyril Dousson , Adel M. Moussa , Edward Bridges , Alistair Stewart , Jing Yang Wang , Benjamin Alexander Mayes
- 申请人： Richard Storer , Francois-Rene Alexandre , Cyril Dousson , Adel M. Moussa , Edward Bridges , Alistair Stewart , Jing Yang Wang , Benjamin Alexander Mayes
- 申请人地址： US MA Cambridge
- 专利权人： Idenix Pharmaceuticals, Inc.
- 当前专利权人： Idenix Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Cambridge
- 代理机构： Jones Day
- 主分类号： A61K31/40
- IPC分类号： A61K31/40 ; C07D209/42
摘要：
3-phosphoindole compounds substantially in the form of a single enantiomer useful for the treatment of Flaviviridae virus infections, and particularly for HIV infections are provided. Also provided are pharmaceutical compositions comprising the 3-phosphoindole compounds alone or in combination with one or more other anti-viral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.
公开/授权文献
- US20080213217A1 Enantiomerically pure phosphoindoles as HIV inhibitors 公开/授权日：2008-09-04
信息查询
